What a disastrous result.Revenue up yet earnings down. The earnings decrease eaten mostly by SHs - partnership model lolz!SH NPAT only $4m but even worse that includes $1.9m in contingent FV Δ* so normalised earnings is a tiny $2.5m or so (assuming tax affected?).Organic revenue growth only a couple of percent, and I reiterate for negative earnings growth.Trailing norm P/E 80+
[* As an aside, IMO the contingent FV Δ is not only incorrect accounting (should be against G/W first), it's an open indication of underperformance of acquas]Yeah yeah markets are forward looking, but have a think about it.How comfortable are people that you'll hit next year's profit target after this miss?And what'll the valuation on that be even then (maybe >30x at norm NPAT) for minimal organic growth. That's the best case.What happens if the cost blowout continues or the acqua binge is stopped?Will you get the revenue target with bank debt now 90% used and at record levels?Almost $40m in net debt - 16x this year's norm profit.Even if you hit next year's profit target (debatable given this year's performance) that's still high (roughly 6 or 7 times).Companies have collapsed at these levels.Mgt conducting strategic review to close MC to IV lolz!More like external capital required to keep the show going. Divi cut a hint. Negative NCA another.The investment thesis now is essentially the greater fool theory.CEO selling shares and almost tripling his cash salary.Like I said before, either valuation gets it or the bankers do.
- Forums
- ASX - By Stock
- KPG
- Ann: KPG FY23 Full Year Results Commentary
KPG
kelly partners group holdings limited
Add to My Watchlist
2.01%
!
$10.68

Ann: KPG FY23 Full Year Results Commentary, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$10.68 |
Change
0.210(2.01%) |
Mkt cap ! $479.5M |
Open | High | Low | Value | Volume |
$10.48 | $10.68 | $10.20 | $445.3K | 43.08K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 800 | $10.26 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$10.74 | 6000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4200 | 12.810 |
1 | 899 | 10.550 |
1 | 153 | 10.400 |
1 | 800 | 10.260 |
2 | 1241 | 10.200 |
Price($) | Vol. | No. |
---|---|---|
10.150 | 250 | 1 |
10.580 | 300 | 1 |
10.740 | 6000 | 1 |
10.800 | 3150 | 2 |
10.850 | 4000 | 1 |
Last trade - 16.10pm 25/06/2025 (20 minute delay) ? |
Featured News
KPG (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
SPONSORED BY The Market Online